Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-04-15 @ 11:21 PM
Study NCT ID:
NCT06046495
Status:
RECRUITING
Last Update Posted:
2025-04-23
First Post:
2023-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Sponsor:
Avistone Biotechnology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PLB1004-I-US01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None